196 related articles for article (PubMed ID: 27837291)
41. CDH1 associated gastric cancer: a report of a family and review of the literature.
Moran CJ; Joyce M; McAnena OJ
Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
[TBL] [Abstract][Full Text] [Related]
42. Hereditary diffuse gastric cancer: a family diagnosis and treatment.
Onitilo AA; Aryal G; Engel JM
Clin Med Res; 2013 Feb; 11(1):36-41. PubMed ID: 22723466
[TBL] [Abstract][Full Text] [Related]
43. [Familial gastric cancer: diagnosis, treatment and periodic surveillance].
Kluijt I; Sijmons RH; Hoogerbrugge N; Vasen HF; Cats A
Ned Tijdschr Geneeskd; 2011; 155():A2731. PubMed ID: 21329544
[TBL] [Abstract][Full Text] [Related]
44. Preemptive total gastrectomy for hereditary gastric cancer.
Medina-Franco H; Barreto-Zuñiga R; García-Alvarez MN
J Gastrointest Surg; 2007 Mar; 11(3):314-7. PubMed ID: 17458604
[TBL] [Abstract][Full Text] [Related]
45. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
[TBL] [Abstract][Full Text] [Related]
46. Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes.
Forrester JD; Foster D; Ford JM; Longacre TA; Ladabaum U; Fry S; Norton JA
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158993
[TBL] [Abstract][Full Text] [Related]
47. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.
Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F
Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492
[TBL] [Abstract][Full Text] [Related]
48. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
[TBL] [Abstract][Full Text] [Related]
49. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
[TBL] [Abstract][Full Text] [Related]
50. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
Stillman MD; Kusche N; Toledano S; Hilfrank KJ; Yoon C; Gabre JT; Rustgi SD; Hur C; Kastrinos F; Ryeom SW; Yoon SS
J Surg Oncol; 2022 Dec; 126(8):1413-1422. PubMed ID: 36063148
[TBL] [Abstract][Full Text] [Related]
51. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
52. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma.
Lee HE; Smyrk TC; Zhang L
Hum Pathol; 2018 Apr; 74():64-72. PubMed ID: 29307626
[TBL] [Abstract][Full Text] [Related]
53. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
Cisco RM; Norton JA
Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
[TBL] [Abstract][Full Text] [Related]
54. A Systematic Review on Clinical and Health-Related Quality of Life Outcomes following Total Gastrectomy in Patients with Hereditary Diffuse Gastric Cancer.
Lim HJ; di Pietro M; O'Neill JR
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339225
[TBL] [Abstract][Full Text] [Related]
55. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
56. Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family.
Hackenson D; Edelman DA; McGuire T; Weaver DW; Webber JD
JSLS; 2010; 14(3):348-52. PubMed ID: 21333186
[TBL] [Abstract][Full Text] [Related]
57. Prophylactic total gastrectomy in the management of hereditary tumor syndromes.
Pantelis D; Hüneburg R; Adam R; Holzapfel S; Gevensleben H; Nattermann J; Strassburg CP; Aretz S; Kalff JC
Int J Colorectal Dis; 2016 Dec; 31(12):1825-1833. PubMed ID: 27682646
[TBL] [Abstract][Full Text] [Related]
58. Prophylactic gastrectomy for CDH1 mutation carriers.
Giarelli E
Clin J Oncol Nurs; 2002; 6(3):161-2. PubMed ID: 11998610
[TBL] [Abstract][Full Text] [Related]
59. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
Black MD; Kaneshiro R; Lai JI; Shimizu DM
Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
[TBL] [Abstract][Full Text] [Related]
60. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
